More Articles

EGA meeting London 2010: monoclonal antibodies and biosimilars guidelines Guidelines | Posted 10/09/2010

In his opening address to the 8th EGA International Symposium on Biosimilar Medicines held in London on 2–3 September 2010, EGA Director General Mr Greg Perry praised the EU for inspiring the rest...

Teva increases its global position with acquisition of Ratiopharm Pharma News | Posted 10/09/2010

Generics are becoming an increasingly lucrative market with good prospects for the future. However, a report by US market data provider BCC Research shows that this is also a bit of an exclusive cl...

Opportunities in the COPD market Reports | Posted 10/09/2010

The increasing elderly population and increases in diagnosis and drug treatment will fuel a steady 4.6% annual growth in the chronic obstructive pulmonary disease (COPD) drug market, says a new rep...

What is ‘tentative approval’ and how does it affect generics? Generics/General | Posted 10/09/2010

Tentative approval by the FDA enables generics access to poor nations under a US initiative, which allows sale of generics to treat conditions where there is a significant public health impact, eve...

More drug recalls due to poor manufacturing Reports | Posted 10/09/2010

The quality of raw materials and contamination is under scrutiny by the FDA once again as Indian generics’ manufacturer Sun Pharmaceutical Industries Ltd is cited for manufacturing violations.

Is China set to lose its low-cost appeal? Reports | Posted 10/09/2010

Over the last few years, with rising costs in Europe and the US, Western pharmaceutical companies have increasingly looked to outsource manufacturing to low-cost countries like China. However, infl...

Pharma price-fixing under renewed investigation Generics/General | Posted 10/09/2010

Some of the world’s biggest drug companies are having once again to face up to price-fixing allegations thanks to the Supreme Court of California. These allegations were dismissed by a lower court...

Indian government encourages biosimilars Policies & Legislation | Posted 03/09/2010

India has, by far, demonstrated the greatest acceptance of biosimilars. In recent years over 50 biopharmaceutical products have been approved for marketing in India, with more than half of them bei...